LEVETIRACETAM
- Product NDC
- 13668-272
- 11-digit product format
- 136680272
- Labeler code
- 13668
- Product ID
- 13668-272_724c2e0f-2d55-4a25-a514-125371becd21
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- LEVETIRACETAM
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Torrent Pharmaceuticals Limited
- Application
- ANDA091338
- Marketing category
- ANDA
- Marketing start
- 2026-01-30
- Substance
- LEVETIRACETAM
- Active strength
- 500 mg/1
- Pharmacologic classes
- Decreased Central Nervous System Disorganized Electrical Activity [PE]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- LEVETIRACETAM
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| LEVETIRACETAM | 500 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 44YRR34555 |
| Rxcui | 807832, 846378 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 13668-272-05 | LEVETIRACETAM | 500 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 500 | | 16 |
| 13668-272-10 | LEVETIRACETAM | 1000 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 1000 | | 16 |
| 13668-272-12 | LEVETIRACETAM | 120 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 120 | | 16 |
| 13668-272-25 | LEVETIRACETAM | 250 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 250 | | 16 |
| 13668-272-60 | LEVETIRACETAM | 60 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 60 | | 16 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| LEVETIRACETAM | ACTIVE INGREDIENT | 44YRR34555 | LEVETIRACETAM TABLET, EXTENDED RELEASE [TORRENT PHARMACEUTICALS LIMITED] | 6 | |
| LEVETIRACETAM | ACTIVE MOIETY | 44YRR34555 | LEVETIRACETAM TABLET, EXTENDED RELEASE [TORRENT PHARMACEUTICALS LIMITED] | 6 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | LEVETIRACETAM TABLET, EXTENDED RELEASE [TORRENT PHARMACEUTICALS LIMITED] | 6 | |
| COLLOIDAL SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | LEVETIRACETAM TABLET, EXTENDED RELEASE [TORRENT PHARMACEUTICALS LIMITED] | 6 | |
| COPOVIDONE | INACTIVE INGREDIENT | D9C330MD8B | LEVETIRACETAM TABLET, EXTENDED RELEASE [TORRENT PHARMACEUTICALS LIMITED] | 6 | |
| HYPROMELLOSES | INACTIVE INGREDIENT | 3NXW29V3WO | LEVETIRACETAM TABLET, EXTENDED RELEASE [TORRENT PHARMACEUTICALS LIMITED] | 6 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | LEVETIRACETAM TABLET, EXTENDED RELEASE [TORRENT PHARMACEUTICALS LIMITED] | 6 | |
| POLYETHYLENE GLYCOL 400 | INACTIVE INGREDIENT | B697894SGQ | LEVETIRACETAM TABLET, EXTENDED RELEASE [TORRENT PHARMACEUTICALS LIMITED] | 6 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | LEVETIRACETAM TABLET, EXTENDED RELEASE [TORRENT PHARMACEUTICALS LIMITED] | 6 | |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|
| 13668-272-05 | 13668027205 | 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (13668-272-05) | 2026-01-30 | No | No | Current |
| 13668-272-10 | 13668027210 | 1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (13668-272-10) | 2026-01-30 | No | No | Current |
| 13668-272-12 | 13668027212 | 120 TABLET, EXTENDED RELEASE in 1 BOTTLE (13668-272-12) | 2026-01-30 | No | No | Current |
| 13668-272-25 | 13668027225 | 250 TABLET, EXTENDED RELEASE in 1 BOTTLE (13668-272-25) | 2026-01-30 | No | No | Current |
| 13668-272-60 | 13668027260 | 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (13668-272-60) | 2026-01-30 | No | No | Current |